Cart is empty More than 10% of fecal immunochemical tests (FIT) used for routine colorectal cancer (CRC) screening in a safety-net health system contained unsatisfactory samples that could not be processed, according to a new study.
More than 10% of fecal immunochemical tests (FIT) used for routine colorectal cancer (CRC) screening in a safety-net health system contained unsatisfactory samples that could not be processed, according to a new study.
Leave A Comment